col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


19 Results       Page 1

 [1] 
Wiley: Fundamental and Clinical Pharmacology
  original article Date Title Authors   All Authors
1 [GO] 2023―Nov―21 An exploratory study of drug concentration and inhibitory effect of cetylpyridinium chloride buccal tablets on SARS-CoV-2 infection among 10 Chinese subjects Yanting Li, Zhenwei Xie, Liming Chen, Xiangxing Liu, Shuang Li, Shichun Ye, et al. (+13)
2 [GO] 2023―Nov―11 Alterations in the gene expression of SARS-COV-2 entry receptors and enzymes in lungs and hearts of controlled and uncontrolled diabetic mice Ohood Alkhawaldeh, Yazun Jarrar, Munir Gharaibeh, Sara Abudahab, Dina Abulebdah, Bashir Jarrar
3 [GO] 2023―Jul―20 Vestibular disorders following BNT162b2 mRNA COVID-19 vaccination: A retrospective case series Helmi Ammar, Christine Le Beller, Didier Bouccara, David Malinvaud, Romain Jouffroy, Agnès Lillo-Le Louet
4 [GO] 2023―May―11 Treatment implications of augmented renal clearance in a critically ill COVID-19 patient: a case report Susan Deenen, Laura F. C. Fransen, Tessa C. C. Jaspers, Jessica D. Workum
5 [GO] 2023―Mar―18 Viral target- and metabolism-based rationale for combined use of recently authorized small molecule COVID-19 medicines: molnupiravir, nirmatrelvir and remdesivir Daisy Yan, Bingfang Yan
6 [GO] 2022―May―14 Melatonin as a complementary and prophylactic agent against COVID-19 in high-risk populations: A narrative review of recent findings from clinical and preclinical studies Abdolkarim Hosseini, Taleb Badri, Hadi Esmaeili Gouvarchin Ghaleh, Kazem Hassanpour, Gholam Hossein Alishiri, Mostafa Akbariqomi, Gholamreza Farnoosh
7 [GO] 2022―May―09 Safety profile of hydroxychloroquine used off-label for the treatment of patients with COVID-19: A descriptive study based on Eudravigilance data Domenico Motola, Giulia Bonaldo, Nicola Montanaro
8 [GO] 2022―May―03 NVX-Cov2373 Novavax Covid-19 vaccine: a further analysis of its efficacy using multiple modes of expression Jean-Louis Montastruc, Pierre Biron, Agnès Sommet
9 [GO] 2021―Jul―16 In vitro inhibition and molecular docking of a new ciprofloxacin chalcone against SARS-CoV-2 main protease Rania Alaaeldin, Muhamad Mustafa, Gamal El-Din A. Abuo-Rahma, Moustafa Fathy
10 [GO] 2021―Jul―12 Efficacy of Covid-19 vaccines: several modes of expression should be presented in scientific publications Jean-Louis Montastruc, Pierre Biron, Agnès Sommet
11 [GO] 2021―May―11 COVID-19 in DMARD-treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database Amandine Dernoncourt, Jean Schmidt, Pierre Duhaut, Sophie Liabeuf, Valérie Gras-Champel, Kamel Masmoudi, et al. (+2)
12 [GO] 2021―Apr―20 Chronic use of Renin-Angiotensin-Aldosterone-System blockers and mortality in COVID-19: a multicenter prospective cohort and literature review Nathalie Gault, Marina Esposito-Farese, Matthieu Revest, Jocelyn Inamo, André Cabie, Élisabeth Polard, et al. (+16)
13 [GO] 2021―Jan―15 A systematic review of experimental evidence for antiviral effects of ivermectin and an in-silico analysis of ivermectin's possible mode of action against SARS-CoV-2 Robert T. Kinobe, Leigh Owens
14 [GO] 2020―Dec―09 Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study Joachim Alexandre, Jean-Luc Cracowski
15 [GO] 2020―Oct―28 Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV study Margaux Lafaurie, Guillaume Martin-Blondel, Pierre Delobel, Sandrine Charpentier, Agnès Sommet, Guillaume Moulis
16 [GO] 2020―Jul―13 Pharmacological agents under investigation in the treatment of coronavirus disease 2019 and the importance of melatonin Hakan Parlakpinar, Seyhan Polat, Hacı Ahmet Acet
17 [GO] 2020―Jul―02 Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments Nicolas Venisse
18 [GO] 2020―Jun―30 Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments Florian Lemaitre, Caroline Solas, Matthieu Grégoire, Laurence Lagarce, Laure Elens, Elisabeth Polard, et al. (+4)
19 [GO] 2020―May―12 Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic Louis Larrouquere, Manon Gabin, Emmanuelle Poingt, Amelle Mouffak, Alex Hlavaty, Marion Lepelley, et al. (+17)
 [1] 

19 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.012 sec